Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TDT 067 topical terbinafine trial in distal subungual toenail onychomycosis
2010-018793-21Phase 3Completed
- Sponsor
- Celtic Pharma
- Start
- Mar 2010
- Modality
- Small Molecules, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in onychomycosis comparing TDT 067, Transfersome vehicle and Non-Transfersome placebo (3 arms). Primary endpoint: Complete cure at Week 52. Started Mar 2010; status: completed.
02
Drugs
TDT-067
03
Conditions
onychomycosis
Beyond the preview
Go deeper on 2010-018793-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018793-21.